Mark Howarth engineers covalent, genetically encoded tagging and site-specific bioconjugation to build modular protein assemblies. His group creates nanoparticle and virus-like platforms for multivalent antigen display, cross-reactive vaccines, and high-contrast live-cell imaging and receptor mapping.